Hazim, Roni A.
Karumbayaram, Saravanan
Jiang, Mei
Dimashkie, Anupama
Lopes, Vanda S.
Li, Douran
Burgess, Barry L.
Vijayaraj, Preethi
Alva-Ornelas, Jackelyn A.
Zack, Jerome A.
Kohn, Donald B.
Gomperts, Brigitte N.
Pyle, April D.
Lowry, William E.
Williams, David S.
Funding for this research was provided by:
National Institutes of Health (R01EY13408, P30EY00331, F31EY026805, R01AR064327)
Esther B. O'Keeffe Foundation
Jean Perkins Foundation
UCLA Eli and Edythe Broad Stem Cell Research Center
Article History
Received: 6 May 2017
Revised: 16 August 2017
Accepted: 29 August 2017
First Online: 2 October 2017
Change Date: 12 February 2019
Change Type: Correction
Change Details: The original article [1] contains an error in the legend of Fig 5 whereby the descriptions for panels 5d and 5e are incorrect; as such, the corrected legend can be viewed below with its respective figure images.
Ethics approval and consent to participate
: Written approvals for human skin biopsy procedures and human fibroblast derivation, culture, and experimental use were obtained from the University of California, Los Angeles, Institutional Review Board (IRB Protocol #11-001087) and the University of California, Los Angeles Stem Cell Research Oversight Committee (UCLA ESCRO Protocol #2010-009-07). Written informed consent was obtained from each individual participant. Cells used in this study were derived in a GMP facility at the UCLA David Geffen School of Medicine. Written approvals for the experiments performed in this study were obtained from the UCLA Institute Biosafety Committee (UCLA IBC Protocol # 110.14.1-f) and the Animal Research Committee (UCLA ARC Protocol #2007-151-23G).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.